[go: up one dir, main page]

NO20075090L - Method of administration of ixabepilone - Google Patents

Method of administration of ixabepilone

Info

Publication number
NO20075090L
NO20075090L NO20075090A NO20075090A NO20075090L NO 20075090 L NO20075090 L NO 20075090L NO 20075090 A NO20075090 A NO 20075090A NO 20075090 A NO20075090 A NO 20075090A NO 20075090 L NO20075090 L NO 20075090L
Authority
NO
Norway
Prior art keywords
ixabepilone
administration
patients
dual
stability
Prior art date
Application number
NO20075090A
Other languages
Norwegian (no)
Inventor
Ismat Ullah
Vijay H Naringrekar
Thomas A Haby
Fahri T Comezoglu
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20075090L publication Critical patent/NO20075090L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Det er gitt metoder for administrering av ixabepilone til pasienter, hvor ixabepilone har formelen . Ett aspekt ved oppfinnelsen omfatter anvendelse av en Y-kobling eller dualkilde administreringsteknikk som gir forbedret ixabepilone-stabilitet og tillater større fleksibilitet i infusjonstid og/eller produktfremstilling.Methods have been provided for the administration of ixabepilone to patients in whom ixabepilone has the formula. One aspect of the invention involves the use of a Y-coupling or dual-source administration technique which provides improved ixabepilone stability and allows greater flexibility in infusion time and / or product preparation.

NO20075090A 2005-03-31 2007-10-09 Method of administration of ixabepilone NO20075090L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66690705P 2005-03-31 2005-03-31
PCT/US2006/011920 WO2006105399A1 (en) 2005-03-31 2006-03-30 Methods for administering ixabepilone

Publications (1)

Publication Number Publication Date
NO20075090L true NO20075090L (en) 2007-12-04

Family

ID=36763031

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075090A NO20075090L (en) 2005-03-31 2007-10-09 Method of administration of ixabepilone

Country Status (5)

Country Link
EP (1) EP1863481A1 (en)
JP (1) JP2008534610A (en)
CN (1) CN101155584A (en)
NO (1) NO20075090L (en)
WO (1) WO2006105399A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009089138A1 (en) * 2008-01-04 2009-07-16 Bristol-Myers Squibb Company Oral administration of ixabepilone
EP2227296B1 (en) 2008-01-08 2015-11-25 Bristol-Myers Squibb Company Combination of anti-ctla4 antibody with tubulin modulating agents for the treatment of proliferative diseases
NZ613167A (en) 2010-12-16 2015-09-25 Univ Texas Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds
ES2822350T3 (en) 2011-04-28 2021-04-30 Platform Brightworks Two Ltd Improved parenteral formulations of lipophilic pharmaceutical agents and methods of preparation and use thereof
CN103908432B (en) * 2013-01-02 2018-09-21 博瑞生物医药（苏州）股份有限公司 A kind of freeze-dried composition and preparation method thereof of Ipsapirone albumin
US9320730B2 (en) * 2014-03-13 2016-04-26 Vasilios Voudouris Bendamustine solid dispersions and continuous infusion

Also Published As

Publication number Publication date
CN101155584A (en) 2008-04-02
EP1863481A1 (en) 2007-12-12
WO2006105399A1 (en) 2006-10-05
JP2008534610A (en) 2008-08-28

Similar Documents

Publication Publication Date Title
ECSP067054A (en) NEW FLUOROGLYCOSIDIC DERIVATIVES OF PIRAZOLES, MEDICINES CONTAINING THESE COMPOUNDS, AND THE USE OF THEMSELVES
PH12019500599A1 (en) Sweet flavor modifier
NZ753358A (en) Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
MY179876A (en) Sweet flavor modifier
SG178952A1 (en) Chemical compounds
NO20065946L (en) DPP-IV inhibitors
NO20075090L (en) Method of administration of ixabepilone
TW200716646A (en) (S)-N-methylnaltrexone
NO20075669L (en) Means for treating involuntary movement
MX2007007845A (en) Sulfonyl pyrrolidines, method for producing the same and their use as drugs.
BR112014033104A2 (en) pesticide compositions and processes related thereto
WO2009111653A3 (en) Antiviral therapeutic agents
NO20083026L (en) Therapeutic agent for diabetes
MX2011011776A (en) Triptolide prodrugs.
WO2007076085A3 (en) Fused pyrimidones and thiopyrimidones, and uses thereof
UA112556C2 (en) INSECTICID DERIVATIVES OF 2-METOXYBENZAMIDES
CY1117397T1 (en) 3-TETEROULULAMINE-PROPIONIC ACID PRODUCTS AND THEIR USE AS PHARMACEUTICALS
CY1118844T1 (en) Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
MX2009000768A (en) Macrocyclic lactams.
DK2471781T3 (en) Benzylaralkyl ether compounds, process for preparing the same, intermediate compounds, use of these compounds, method of treatment and / or prevention, pharmaceutical composition and drug containing the same.
UA100862C2 (en) Hexatomic aromatic compounds, preparation and use thereof
NO20063611L (en) Methods for preparing aryl and heteroarylsulfonyl halides
ATE556062T1 (en) 3,4-DIHYDROQUINAZOLINE DERIVATIVES
NO20091386L (en) Fenyloksyanilinderivater
DK1615656T3 (en) Immunomodulatory product obtained from a Bifidobacterium culture and preparations containing the same

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application